Pfizer holds diabetes awareness workshopsPfizer, the leading pharmaceutical company, organised diabetic foot awareness workshops in association with Dubai Health Authority (DHA) and local and international experts in Sharjah, Dubai and Abu Dhabi. Globally, 40 per cent to More… |
Cancer drugs proving worth earlier in testingMichael Weitz was out of options. The Californian had endured chemotherapy, radiation and surgery but his lung cancer still spread to his bones and brain. With time running out, the emergency room physician entered a Phase I study More… |
Vaccination 'key to prevent pneumococcal diseases'Experts have emphasised the role of vaccination in preventing the risk of contracting pneumococcal diseases by adults over the age of 50. World class experts from the fields of research, diagnos More… |
Pfizer, J&J scrap Alzheimer's drugs planPfizer and Johnson & Johnson scrapped further studies of one of the most anticipated experimental drugs for Alzheimer's disease after it failed to help patients with the memory-robbing condition in a second high-profile More… |
Pfizer drug effective in rare children's cancersA Pfizer lung cancer drug appears to be a highly effective treatment for children with a rare but aggressive type of lymphoma and other cancers, according to data from an early stage study released on Wednesday. More… |
FDA staff question Pfizer arthritis drug benefitsUS drug reviewers on Monday questioned whether the benefits of Pfizer's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections. The Food and Drug Administration staff said the drug, cal More… |
Nestle to buy Pfizer Nutrition for $11.9bnSwiss food group Nestle is to buy US drugmaker Pfizer's nutrition business for $11.85 billion, beating out French rival Danone as both battle to gain preeminence in the lucrative baby food market. Nestl More… |
Nestle near buying Pfizer's baby formulaNestle, the world's biggest food group, is closing in on a deal to buy Pfizer's infant nutrition business for up to $10 billion to boost its business in China and extend its lead in the world of formula milk for babies, sources familiar with More… |
Cardiovascular patients need more treatmentPatients across the Gulf who are at high risk of developing cardiovascular disease need more aggressive treatment to mitigate these risks, such as treating high cholesterol levels, according to medical experts at the Pace event held recently. More… |
Bristol, Pfizer clot drug fails to help ill patientsBristol-Myers Squibb and Pfizer's apixaban failed to significantly help seriously ill patients cut their risk of dangerous blood clots, according to clinical data released on Sunday. The drug showed a trend toward cuttin More… |








